vs
LivaNova PLC（LIVN）与Reddit, Inc.（RDDT）财务数据对比。点击上方公司名可切换其他公司
Reddit, Inc.的季度营收约是LivaNova PLC的1.8倍（$663.0M vs $360.9M），Reddit, Inc.净利率更高（30.8% vs 8.6%，领先22.2%），Reddit, Inc.同比增速更快（69.0% vs 12.1%），Reddit, Inc.自由现金流更多（$311.0M vs $50.2M），过去两年Reddit, Inc.的营收复合增速更高（53.6% vs 10.6%）
LivaNova PLC是一家深耕医疗设备领域的企业，总部位于英国，核心业务为研发心脏外科及神经调控类医疗设备。该公司由美国Cyberonics公司与意大利Sorin公司于2015年以27亿美元对价合并成立，目前在纳斯达克挂牌交易，股票代码为LIVN。
Reddit是美国知名的社交新闻聚合与论坛类社交媒体平台，注册用户可发布链接、文字帖、图片、视频等各类内容，其他用户可对内容进行点赞或点踩，内容按主题归类到用户创建的子板块中，获赞更高的内容会排在板块前列，热度足够的内容还将展示在全站首页。
LIVN vs RDDT — 直观对比
营收规模更大
RDDT
是对方的1.8倍
$360.9M
营收增速更快
RDDT
高出56.9%
12.1%
净利率更高
RDDT
高出22.2%
8.6%
自由现金流更多
RDDT
多$260.8M
$50.2M
两年增速更快
RDDT
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $360.9M | $663.0M |
| 净利润 | $30.9M | $204.0M |
| 毛利率 | 65.2% | 100.0% |
| 营业利润率 | 11.8% | 0.0% |
| 净利率 | 8.6% | 30.8% |
| 营收同比 | 12.1% | 69.0% |
| 净利润同比 | -44.7% | 680.0% |
| 每股收益（稀释后） | $0.57 | $1.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LIVNRDDT
| Q1 26 | — | $663.0M | ||
| Q4 25 | $360.9M | $725.6M | ||
| Q3 25 | $357.8M | $584.9M | ||
| Q2 25 | $352.5M | $499.6M | ||
| Q1 25 | $316.9M | $392.4M | ||
| Q4 24 | $321.8M | $427.7M | ||
| Q3 24 | $318.1M | $348.4M | ||
| Q2 24 | $318.6M | $281.2M |
净利润LIVNRDDT
| Q1 26 | — | $204.0M | ||
| Q4 25 | $30.9M | $251.6M | ||
| Q3 25 | $26.8M | $162.7M | ||
| Q2 25 | $27.2M | $89.3M | ||
| Q1 25 | $-327.3M | $26.2M | ||
| Q4 24 | $55.9M | $71.0M | ||
| Q3 24 | $33.0M | $29.9M | ||
| Q2 24 | $16.3M | $-10.1M |
毛利率LIVNRDDT
| Q1 26 | — | 100.0% | ||
| Q4 25 | 65.2% | 91.9% | ||
| Q3 25 | 68.4% | 91.0% | ||
| Q2 25 | 67.8% | 90.8% | ||
| Q1 25 | 69.7% | 90.5% | ||
| Q4 24 | 68.2% | 92.6% | ||
| Q3 24 | 70.8% | 90.1% | ||
| Q2 24 | 68.7% | 89.5% |
营业利润率LIVNRDDT
| Q1 26 | — | 0.0% | ||
| Q4 25 | 11.8% | 31.9% | ||
| Q3 25 | 15.1% | 23.7% | ||
| Q2 25 | 15.4% | 13.6% | ||
| Q1 25 | 15.3% | 1.0% | ||
| Q4 24 | 11.5% | 12.4% | ||
| Q3 24 | 11.2% | 2.0% | ||
| Q2 24 | 12.6% | -11.0% |
净利率LIVNRDDT
| Q1 26 | — | 30.8% | ||
| Q4 25 | 8.6% | 34.7% | ||
| Q3 25 | 7.5% | 27.8% | ||
| Q2 25 | 7.7% | 17.9% | ||
| Q1 25 | -103.3% | 6.7% | ||
| Q4 24 | 17.4% | 16.6% | ||
| Q3 24 | 10.4% | 8.6% | ||
| Q2 24 | 5.1% | -3.6% |
每股收益（稀释后）LIVNRDDT
| Q1 26 | — | $1.01 | ||
| Q4 25 | $0.57 | $1.24 | ||
| Q3 25 | $0.49 | $0.80 | ||
| Q2 25 | $0.50 | $0.45 | ||
| Q1 25 | $-6.01 | $0.13 | ||
| Q4 24 | $1.04 | $4.76 | ||
| Q3 24 | $0.60 | $0.16 | ||
| Q2 24 | $0.30 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $635.6M | $1.4B |
| 总债务越低越好 | $376.1M | — |
| 股东权益账面价值 | $1.2B | $3.2B |
| 总资产 | $2.6B | $3.5B |
| 负债/权益比越低杠杆越低 | 0.31× | — |
8季度趋势，按日历期对齐
现金及短期投资LIVNRDDT
| Q1 26 | — | $1.4B | ||
| Q4 25 | $635.6M | $953.6M | ||
| Q3 25 | $646.1M | $911.7M | ||
| Q2 25 | $593.6M | $734.1M | ||
| Q1 25 | $738.4M | $635.7M | ||
| Q4 24 | $428.9M | $562.1M | ||
| Q3 24 | $346.4M | $515.9M | ||
| Q2 24 | $329.2M | $468.0M |
总债务LIVNRDDT
| Q1 26 | — | — | ||
| Q4 25 | $376.1M | — | ||
| Q3 25 | $434.5M | — | ||
| Q2 25 | $430.6M | — | ||
| Q1 25 | $628.2M | — | ||
| Q4 24 | $627.0M | — | ||
| Q3 24 | $625.5M | — | ||
| Q2 24 | $624.5M | — |
股东权益LIVNRDDT
| Q1 26 | — | $3.2B | ||
| Q4 25 | $1.2B | $2.9B | ||
| Q3 25 | $1.2B | $2.6B | ||
| Q2 25 | $1.1B | $2.4B | ||
| Q1 25 | $1.0B | $2.2B | ||
| Q4 24 | $1.3B | $2.1B | ||
| Q3 24 | $1.3B | $2.0B | ||
| Q2 24 | $1.2B | $1.9B |
总资产LIVNRDDT
| Q1 26 | — | $3.5B | ||
| Q4 25 | $2.6B | $3.2B | ||
| Q3 25 | $2.6B | $2.9B | ||
| Q2 25 | $2.5B | $2.6B | ||
| Q1 25 | $2.6B | $2.4B | ||
| Q4 24 | $2.5B | $2.3B | ||
| Q3 24 | $2.5B | $2.2B | ||
| Q2 24 | $2.5B | $2.1B |
负债/权益比LIVNRDDT
| Q1 26 | — | — | ||
| Q4 25 | 0.31× | — | ||
| Q3 25 | 0.38× | — | ||
| Q2 25 | 0.38× | — | ||
| Q1 25 | 0.61× | — | ||
| Q4 24 | 0.47× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.50× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $82.4M | — |
| 自由现金流经营现金流 - 资本支出 | $50.2M | $311.0M |
| 自由现金流率自由现金流/营收 | 13.9% | 46.9% |
| 资本支出强度资本支出/营收 | 8.9% | — |
| 现金转化率经营现金流/净利润 | 2.67× | — |
| 过去12个月自由现金流最近4个季度 | $173.3M | $868.6M |
8季度趋势，按日历期对齐
经营现金流LIVNRDDT
| Q1 26 | — | — | ||
| Q4 25 | $82.4M | $266.8M | ||
| Q3 25 | $85.1M | $185.2M | ||
| Q2 25 | $62.9M | $111.3M | ||
| Q1 25 | $24.0M | $127.6M | ||
| Q4 24 | $78.7M | $90.0M | ||
| Q3 24 | $51.0M | $71.6M | ||
| Q2 24 | $43.4M | $28.4M |
自由现金流LIVNRDDT
| Q1 26 | — | $311.0M | ||
| Q4 25 | $50.2M | $263.6M | ||
| Q3 25 | $62.2M | $183.1M | ||
| Q2 25 | $47.8M | $110.8M | ||
| Q1 25 | $13.2M | $126.6M | ||
| Q4 24 | $68.3M | $89.2M | ||
| Q3 24 | $32.8M | $70.3M | ||
| Q2 24 | $31.2M | $27.2M |
自由现金流率LIVNRDDT
| Q1 26 | — | 46.9% | ||
| Q4 25 | 13.9% | 36.3% | ||
| Q3 25 | 17.4% | 31.3% | ||
| Q2 25 | 13.6% | 22.2% | ||
| Q1 25 | 4.2% | 32.3% | ||
| Q4 24 | 21.2% | 20.8% | ||
| Q3 24 | 10.3% | 20.2% | ||
| Q2 24 | 9.8% | 9.7% |
资本支出强度LIVNRDDT
| Q1 26 | — | — | ||
| Q4 25 | 8.9% | 0.4% | ||
| Q3 25 | 6.4% | 0.4% | ||
| Q2 25 | 4.3% | 0.1% | ||
| Q1 25 | 3.4% | 0.2% | ||
| Q4 24 | 3.2% | 0.2% | ||
| Q3 24 | 5.7% | 0.4% | ||
| Q2 24 | 3.8% | 0.4% |
现金转化率LIVNRDDT
| Q1 26 | — | — | ||
| Q4 25 | 2.67× | 1.06× | ||
| Q3 25 | 3.18× | 1.14× | ||
| Q2 25 | 2.32× | 1.25× | ||
| Q1 25 | — | 4.88× | ||
| Q4 24 | 1.41× | 1.27× | ||
| Q3 24 | 1.55× | 2.40× | ||
| Q2 24 | 2.65× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LIVN
| Other | $169.4M | 47% |
| Neuromodulation Segment | $119.7M | 33% |
| Cardiopulmonary Segment | $71.8M | 20% |
RDDT
暂无分部数据
